Healthcare provider profile · identity verified

Subhasis Kumar Maitra, MD

Internal Medicine · AVONDALE, AZ · NPI 1487673760

Profile state: partd only Open Payments: 2025 Medicare Part D: 2024 Last identity check: 2026-08-10 Page data build: 2026-08-12

Verified facts

What the public records show

We did not find matching Open Payments records for this doctor in 2025.

These records do not establish that a payment influenced prescribing or medical care.

Payment overview · 2025

General Payments

We did not find matching Open Payments records for this doctor in the selected program year.

Separate record types

Research & Ownership

Research Payments (direct recipient): not present in the loaded data

Associated Research Funding (for example, named PI): not present in the loaded data

Ownership / Investment: not present in the loaded data

These categories are never added into the General Payments headline. Associated research funding must not be described as money the doctor personally received unless the source record supports that conclusion.

Analysis 1 · Payment-linked products

Products named in Open Payments records

No payment-linked product analysis is available because no matching General Payment records were found for the selected year.

Public prescribing for products named in payments

There is no explicit payment-product set available for a Part D comparison.

The presence of the same drug in both datasets does not show that a payment caused or influenced a prescription.

Analysis 2 · Same-company prescribing overlap

Drugs reported in other payments from the same company that also appear in Medicare Part D

This analysis is independent from products named on this doctor’s individual payment records. A row appears only when the exact Open Payments reporting entity paid this doctor, that same reporting entity reported the drug or biological on at least 10 loaded General Payment records involving at least 2 distinct recipient NPIs, and this doctor has the same non-generic brand in public Part D data. This does not mean the company owns or manufactures the drug.

There is no payer-company set available for this comparison.

These facts do not show that a payment was for the drug, that the company owns or manufactures the drug, or that a payment caused or influenced prescribing.

Public Medicare Part D data

Provider-and-drug rows loaded for 2024

Brand	Generic	Claims	Beneficiaries
Atorvastatin Calcium	Atorvastatin Calcium	401	137
Amlodipine Besylate	Amlodipine Besylate	219	64
Levothyroxine Sodium	Levothyroxine Sodium	186	61
Lisinopril	Lisinopril	161	53
Losartan Potassium	Losartan Potassium	154	48
Rosuvastatin Calcium	Rosuvastatin Calcium	105	40
Metformin Hcl	Metformin Hcl	102	37
Gabapentin	Gabapentin	99	31
Omeprazole	Omeprazole	96	34
Alendronate Sodium	Alendronate Sodium	80	25
Pantoprazole Sodium	Pantoprazole Sodium	68	24
Ozempic	Semaglutide	65	20
Finasteride	Finasteride	61	18
Amoxicillin-Clavulanate Potass	Amoxicillin/Potassium Clav	59	54
Albuterol Sulfate Hfa	Albuterol Sulfate	58	27
Tamsulosin Hcl	Tamsulosin Hcl	58	19
Famotidine	Famotidine	54	18
Duloxetine Hcl	Duloxetine Hcl	53	14
Metoprolol Succinate	Metoprolol Succinate	53	16
Ezetimibe	Ezetimibe	52	16
Allopurinol	Allopurinol	50	12
Metoprolol Tartrate	Metoprolol Tartrate	49	18
Trazodone Hcl	Trazodone Hcl	49	15
Furosemide	Furosemide	43	12
Fluticasone Propionate	Fluticasone Propionate	41	18
Sertraline Hcl	Sertraline Hcl	41	16
Hydrochlorothiazide	Hydrochlorothiazide	40	16
Carvedilol	Carvedilol	39	11
Fluoxetine Hcl	Fluoxetine Hcl	38	11
Lantus Solostar	Insulin Glargine,hum.Rec.Anlog	38	14
Montelukast Sodium	Montelukast Sodium	36	14
Mupirocin	Mupirocin	36	22
Eliquis	Apixaban	35	suppressed
Meloxicam	Meloxicam	35	18
Pravastatin Sodium	Pravastatin Sodium	35	11
Fenofibrate	Fenofibrate	34	13
Azithromycin	Azithromycin	32	31
Prednisone	Prednisone	32	21
Cephalexin	Cephalexin	28	23
Pregabalin	Pregabalin	28	suppressed
Clopidogrel	Clopidogrel Bisulfate	27	11
Tramadol Hcl	Tramadol Hcl	27	suppressed
Valsartan	Valsartan	26	suppressed
Atenolol	Atenolol	21	suppressed
Mounjaro	Tirzepatide	21	suppressed
Metformin Hcl Er	Metformin Hcl	19	suppressed
Oxybutynin Chloride Er	Oxybutynin Chloride	19	suppressed
Glimepiride	Glimepiride	18	suppressed
Doxazosin Mesylate	Doxazosin Mesylate	17	suppressed
Glipizide	Glipizide	17	suppressed
Nifedipine Er	Nifedipine	17	suppressed
Pioglitazone Hcl	Pioglitazone Hcl	17	suppressed
Azelastine Hcl	Azelastine Hcl	16	suppressed
Cefdinir	Cefdinir	15	15
Jardiance	Empagliflozin	15	suppressed
Paroxetine Hcl	Paroxetine Hcl	15	suppressed
Sulfamethoxazole-Trimethoprim	Sulfamethoxazole/Trimethoprim	15	suppressed
Ibuprofen	Ibuprofen	14	suppressed
Losartan-Hydrochlorothiazide	Losartan/Hydrochlorothiazide	14	suppressed
Trulicity	Dulaglutide	14	suppressed
Ciprofloxacin Hcl	Ciprofloxacin Hcl	13	suppressed
Doxycycline Hyclate	Doxycycline Hyclate	13	13
Escitalopram Oxalate	Escitalopram Oxalate	13	suppressed
Terazosin Hcl	Terazosin Hcl	13	suppressed
Trospium Chloride	Trospium Chloride	13	suppressed
Zolpidem Tartrate	Zolpidem Tartrate	13	suppressed
Celecoxib	Celecoxib	12	suppressed
Januvia	Sitagliptin Phosphate	12	suppressed
Memantine Hcl	Memantine Hcl	12	suppressed
Triamcinolone Acetonide	Triamcinolone Acetonide	12	suppressed
Venlafaxine Hcl Er	Venlafaxine Hcl	12	suppressed
Ventolin Hfa	Albuterol Sulfate	12	suppressed
Benazepril Hcl	Benazepril Hcl	11	suppressed
Bupropion Xl	Bupropion Hcl	11	suppressed
Fluconazole	Fluconazole	11	suppressed
Hydralazine Hcl	Hydralazine Hcl	11	suppressed
Insulin Lispro Kwikpen U-100	Insulin Lispro	11	suppressed
Lorazepam	Lorazepam	11	suppressed
Oxycodone-Acetaminophen	Oxycodone Hcl/Acetaminophen	11	suppressed
Tizanidine Hcl	Tizanidine Hcl	11	suppressed
Triamterene-Hydrochlorothiazid	Triamterene/Hydrochlorothiazid	11	suppressed
Valacyclovir	Valacyclovir Hcl	11	suppressed

Timeline

Payment and prescribing data by year

Open Payments and Medicare Part D may refer to different years. They are shown separately rather than aligned as if they describe the same period.

Year	General Payments	Main payer	Explicit products	Company overlaps	Part D coverage
2025	—	—	—	—	—
2024	—	—	—	—	Complete

Questions to ask

Questions you could discuss with your doctor

Are there reasonable alternatives I should understand when we discuss treatment options?
How should I interpret the industry-payment records shown here in the context of my care?

These are general questions generated from reviewed templates. They are not personalized medical advice.

Sources and limitations

How to read this page

Payment and Medicare prescribing data can cover different years; every comparison shows both years explicitly.
Part D does not represent a doctor’s entire practice; it excludes many patients and is subject to CMS public-release thresholds.
Company–drug relationships must have an auditable source, a precise relationship type, and a valid evidence period. Unresolved mappings are not published.
Generic drug claims are not attributed to a specific manufacturer without manufacturer-level evidence.
When a source extract is incomplete, missing rows are never treated as proof of no payments or no prescriptions.

Loaded source releases

Dataset	Year	Publication	Source
CMS Open Payments — General Payments	2025	2026-06-30	Original source
Medicare Part D Prescribers by Provider and Drug	2024	2026-05-06	Original source
NPPES Data Dissemination V2	current / reference data	2026-08-10	Original source

Methodology version: 2.1

Editorial template version: 2.4

Product contract version: 2.0

Schema version: 0.7.0

Page data build: 2026-08-12T23:34:59.370714+00:00

Publication policy: eligible for indexing after public-launch controls are enabled

Full methodology · Questions & answers · Report a possible error